Paper II — 2023 March (Supplementary) (2010 Scheme) — Q9
2 min read
Paper II
2023 March (Supplementary) (2010 Scheme)
Question
5HT3 Antagonist (eg. ondansetron) is used in Chemotherapy induced vomiting
Q91 marksShort Answers
Answer
5-HT3 receptor antagonists block serotonin’s action both peripherally (at vagal afferents, where enterochromaffin cells release serotonin in response to chemotherapy-induced GI mucosal damage) and centrally at the chemoreceptor trigger zone. Because chemotherapy-induced nausea and vomiting involves both of these mechanisms simultaneously, blocking serotonin at both sites addresses the dominant pathway driving CINV specifically, making this class first-line — unlike other antiemetic classes that address only one component (e.g. D2 antagonists) or none of the serotonin-mediated pathway at all.